TRANSFORMING FRACTURE RISK
ASSESSMENT FOR CANCER PATIENTS
WITH VERTEBRAL METASTASES
Computer-aided effective fracture risk stratification of patients with vertebral metastases for personalised treatment through robust computational models validated in clinical settings

METASTRA Symposium at EORS 2025

METASTRA Symposium at EORS 2025

The METASTRA project will be presented at the upcoming European Orthopaedic Research Society (EORS) 2025 conference, taking place in Davos, Switzerland. The dedicated METASTRA symposium is scheduled for June 19th.

The session will feature multiple presentations highlighting METASTRA’s ongoing work on developing advanced computational tools for fracture risk stratification in patients with vertebral metastases. Topics will include:

  • Development and validation of AI-driven and physiology-based biomechanical models;
  • Biomechanical experiments on metastatic vertebrae;
  • 3D finite element modeling of the bone-lesion interface;
  • Spinal load prediction using musculoskeletal and statistical shape modeling;
  • The clinical need for improved fracture risk assessment in metastatic spinal disease.

The METASTRA approach aims to support clinicians with more accurate and personalised decision-making, potentially reducing both unnecessary surgeries and the risk of debilitating fractures.

Find the full EORS 2025 program here.

We are looking forward to sharing our progress with the orthopedic research community at EORS 2025!